Elion Oncology, Inc. — Form D
Elion Oncology, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-26. $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-09-26
- Form: D
- Accession: 0001785673-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.0M
- Investors: 1
- Date of first sale: 2019-09-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-349693
Issuer
- Name: Elion Oncology, Inc.
- CIK: 0001785673
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2016
- Address: 4800 HAMPDEN LANE, BETHESDA, MD, 20814
- Phone: 301-651-4256
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| R. MICHAEL FLOYD | Director | BETHESDA, MD |
| LORENZO MICHAEL LEONI | Director | BETHESDA, MD |
| JAMIE MICHAEL OLIVER | Director | BETHESDA, MD |
| R. MICHAEL FLOYD | Executive Officer | BETHESDA, MD |
| LORENZO MICHAEL LEONI | Executive Officer | BETHESDA, MD |
| R. MICHAEL FLOYD | Promoter | BETHESDA, MD |
More